ClinicalTrials.Veeva

Menu

Screening for Neonatal Jaundice With a Mobile Health Device: a Validation Study in Oaxaca, Mexico.

N

Norwegian University of Science and Technology

Status

Completed

Conditions

Jaundice, Neonatal

Treatments

Device: Screening for neonatal jaundice with a mobile health device

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT06276582
519379-2

Details and patient eligibility

About

The performance and accuracy of the smartphone application (app) Picterus Jaundice Pro (PicterusJP) will be validated by a cross-sectional study conducted in low resource settings in Mexico. Physics-based and machine learning-based models will be used to analyze the images obtained with the app and its performance will be compared.

Full description

A cross-sectional prospective study is taken place at Hospital General de Zona 1 in the city of Oaxaca, Mexico.

Participants are recruited from the maternity ward and emergency room and data collection is conducted by one experienced pediatrician and one paediatrics' resident. After informed consent is obtained, background data including time and date or birth, birth weight, gestational age, parent's skin type according to Fitzpatrick scale and newborn's skin color according to Neomar's scale is being collected. Visual assessment is performed by the researchers using Kramer's scale. To obtain the bilirubin measurements with the smartphone app Picterus Jaundice Pro (Picterus JP), the calibration card is placed on the newborn's chest and a set of six images, 3 with and 3 without flash, are captured. The smartphones used to capture the images are Samsung A23, iPhone 11 and iPhone 15 Pro.

Total serum bilirubin (TSB) levels are measured with a blood sample obtained within one hour of capturing the images and analyzed at the hospital laboratory facilities.

Demographic and clinical characteristics will be analyzed by descriptive statistic.

Bilirubin measurements correlation between Picterus JP using both models and TSB will be determined by Pearson's correlation coefficient. Systematic over or underestimation of bilirubin levels will be evaluated using Bland-Altman plots. Accuracy measurements will be determined using receiver operating characteristics (ROC) and area under the curve (AUC) analysis. To compare the correlations from both models, Fisher's r to z transformation approach will be applied

Enrollment

177 patients

Sex

All

Ages

1 to 14 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • gestational age of 37 weeks or more
  • birth weight of 2500 g and above
  • newborns in whom a blood test had been ordered for any reason, irrespective of the study

Exclusion criteria

  • newborns with congenital diseases
  • newborns transferred to pediatric wards for reasons unrelated to neonatal jaundice
  • newborns who had undergone phototherapy

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

177 participants in 1 patient group

Screening for neonatal jaundice with a mobile health device
Experimental group
Description:
Neonatal jaundice will be screened using the app Picterus JP and the results will be compared to the total serum bilirubin level from a blood test.
Treatment:
Device: Screening for neonatal jaundice with a mobile health device

Trial contacts and locations

1

Loading...

Central trial contact

Gabriela Jimenez Diaz; Jennifer Infanti

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems